China Biotech in Review: Sagent Buys Out China JV Partner for $25 Million

Published May 14, 2013

China Biotech In Review: Sagent Buys Out China JV Partner For Million

Filed under: Drug Treatment Chicago

Sagent Pharmaceuticals (NSDQ: SGNT), a Chicago-area maker of generic injectible drugs, will acquire its partner's 50% interest in a China JV for $ 25 million (see story). Chengdu Kanghong … Vectibix is a treatment for colorectal cancer. In addition to …
Read more on Seeking Alpha

Lindsay Lohan and Adderall: Illegal drugs are not the only addictions

Filed under: Drug Treatment Chicago

According to Drugs.com, Adderall "contains a combination of amphetamine and dextroamphetamine," and it's officially used to "treat narcolepsy and attention deficit hyperactivity disorder (ADHD)." Supposedly, Lohan would only seek treatment if she were …
Read more on Examiner.com

Today's High Gainers: Cellceutix Corp (OTCBB:CTIX), MannKind Corporation …

Filed under: Drug Treatment Chicago

Cellceutix is a Beverly, Massachusetts-based clinical stage biotechnology company focused on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease. … announced that …
Read more on NIS